^
Association details:
| Biomarker: | STAT5b-RARA fusion |
|---|---|
| Cancer: | Acute Promyelocytic Leukemia |
| Regimen: | (aclarubicin + cytarabine + decitabine + granulocyte-colony stimulating factor (GCSF)) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
Does acute promyelocytic leukemia patient with the STAT5B/RARa fusion gene respond well to decitabine?
Published date:
10/23/2020
Excerpt:
The patient was diagnosed as STAT5b-RARa-positive APL based on the clinical and laboratory findings...The patient relapsed soon after his first molecular complete remission (CRm), fortunately, he got a second CRm with DCAG.
DOI:
10.1097/MD.0000000000022923
